Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


Socioeconomic status, race and COPD health outcomes.

Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C.

J Epidemiol Community Health. 2011 Jan;65(1):26-34. doi: 10.1136/jech.2009.089722. Epub 2009 Oct 23.


The impact of SHS exposure on health status and exacerbations among patients with COPD.

Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Sanchez G, Blanc PD.

Int J Chron Obstruct Pulmon Dis. 2009;4:169-76. Epub 2009 May 7.


Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease.

Omachi TA, Sarkar U, Yelin EH, Blanc PD, Katz PP.

J Gen Intern Med. 2013 Jan;28(1):74-81. doi: 10.1007/s11606-012-2177-3. Epub 2012 Aug 14.


Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997. Epub 2012 Nov 1.


Socioeconomic gradients in tiotropium use among adults with COPD.

Blanc PD, Eisner MD, Yelin EH, Earnest G, Balmes JR, Gregorich SE, Katz PP.

Int J Chron Obstruct Pulmon Dis. 2008;3(3):483-90.


Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.

Simoni-Wastila L, Wei YJ, Qian J, Zuckerman IH, Stuart B, Shaffer T, Dalal AA, Bryant-Comstock L.

Am J Geriatr Pharmacother. 2012 Jun;10(3):201-10. doi: 10.1016/j.amjopharm.2012.04.002. Epub 2012 Apr 21.


Ethnicity and risk of hospitalization for asthma and chronic obstructive pulmonary disease.

Tran HN, Siu S, Iribarren C, Udaltsova N, Klatsky AL.

Ann Epidemiol. 2011 Aug;21(8):615-22. doi: 10.1016/j.annepidem.2010.10.015. Epub 2011 Mar 17.


Development of disability in chronic obstructive pulmonary disease: beyond lung function.

Eisner MD, Iribarren C, Blanc PD, Yelin EH, Ackerson L, Byl N, Omachi TA, Sidney S, Katz PP.

Thorax. 2011 Feb;66(2):108-14. doi: 10.1136/thx.2010.137661. Epub 2010 Nov 3.


Effect of race on asthma management and outcomes in a large, integrated managed care organization.

Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD.

Arch Intern Med. 2007 Sep 24;167(17):1846-52.


Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Blanc PD.

Am J Epidemiol. 2008 May 1;167(9):1090-101. doi: 10.1093/aje/kwn025. Epub 2008 Mar 14.


Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.


Race and health profiles in the United States: an examination of the social gradient through the 2009 CHIS adult survey.

Nguyen AB, Moser R, Chou WY.

Public Health. 2014 Dec;128(12):1076-86. doi: 10.1016/j.puhe.2014.10.003. Epub 2014 Nov 25.


Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA.

Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157.


Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.

Jakobsen L, Niemann T, Thorsgaard N, Thuesen L, Lassen JF, Jensen LO, Thayssen P, Ravkilde J, Tilsted HH, Mehnert F, Johnsen SP.

Circ Cardiovasc Interv. 2012 Oct;5(5):641-8. doi: 10.1161/CIRCINTERVENTIONS.112.968271. Epub 2012 Oct 2.


Low socioeconomic status is associated with chronic obstructive airway diseases.

Kanervisto M, Vasankari T, Laitinen T, Heliƶvaara M, Jousilahti P, Saarelainen S.

Respir Med. 2011 Aug;105(8):1140-6. doi: 10.1016/j.rmed.2011.03.008. Epub 2011 Apr 2.


Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.

Bertens LC, Reitsma JB, Moons KG, van Mourik Y, Lammers JW, Broekhuizen BD, Hoes AW, Rutten FH.

Int J Chron Obstruct Pulmon Dis. 2013;8:493-9. doi: 10.2147/COPD.S49609. Epub 2013 Oct 10.


Racial differences in waiting list outcomes in chronic obstructive pulmonary disease.

Lederer DJ, Benn EK, Barr RG, Wilt JS, Reilly G, Sonett JR, Arcasoy SM, Kawut SM.

Am J Respir Crit Care Med. 2008 Feb 15;177(4):450-4. Epub 2007 Nov 15.


Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.


Race/ethnicity, socioeconomic status, and lifetime morbidity burden in the women's health initiative: a cross-sectional analysis.

Gold R, Michael YL, Whitlock EP, Hubbell FA, Mason ED, Rodriguez BL, Safford MM, Sarto GE.

J Womens Health (Larchmt). 2006 Dec;15(10):1161-73.


Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.

Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, Marciniuk DD, Maltais F, Buist AS, O'Donnell DE, Sin DD, Aaron SD; CanCOLD Collaborative Research Group..

Thorax. 2014 Aug;69(8):709-17. doi: 10.1136/thoraxjnl-2013-205048. Epub 2014 Apr 4.

Supplemental Content

Support Center